Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4175252
Max Phase: Preclinical
Molecular Formula: C57H96N12O13
Molecular Weight: 1157.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4175252
Max Phase: Preclinical
Molecular Formula: C57H96N12O13
Molecular Weight: 1157.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C(C)C
Standard InChI: InChI=1S/C57H96N12O13/c1-29(2)25-40(61-36(13)71)51(76)60-34(11)49(74)63-41(26-30(3)4)52(77)62-39(17-14-15-23-58)50(75)65-43(28-37-19-21-38(72)22-20-37)53(78)64-42(27-31(5)6)54(79)67-46(33(9)10)56(81)68-47(35(12)70)57(82)69-24-16-18-44(69)55(80)66-45(32(7)8)48(59)73/h19-22,29-35,39-47,70,72H,14-18,23-28,58H2,1-13H3,(H2,59,73)(H,60,76)(H,61,71)(H,62,77)(H,63,74)(H,64,78)(H,65,75)(H,66,80)(H,67,79)(H,68,81)/t34-,35+,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: AUAONPWHAGVHDU-IDKRDLHQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1157.47 | Molecular Weight (Monoisotopic): 1156.7220 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):